Gene Therapy Struggles in Market

Although it was eagerly anticipated, commercial sales of gene therapy are disappointing. BioMarin’s hemophilia treatment Roctavian had only one US patient last year. And more gene therapy products are in the pipeline from competitors. For more info click here.

Source: Communiqué, LA Kelley Communications, Inc., April 2024

Back to all News